ingredient Eribulin Mesylate 0.5mg
substitutes Eribulin Mesylate 0.5mg
treatment Treatment of Metastatic breast cancer.
Shipping class Room Temperature
Medicine Overview by Anukar Pharmacy
( Halaven 0.5 mg Injection, Eisai )
TreatmentHalaven 0.5 mg Injection is used in the treatment of Metastatic breast cancer.
Side EffectsAnemia (low number of red blood cells), Weakness, Hair loss, Nausea, Constipation, Decreased white blood cell count, Fatigue, Peripheral neuropathy (tingling and numbness of feet and hand)
Method of UseYour doctor or nurse will give you this medicine. Kindly do not self administer.
How Halaven 0.5 mg Injection, Eisai WorksHalaven 0.5 mg Injection is an anticancer medication. It works by interfering with the microtubule structures which help the cancer cells to divide and multiply. This slows the growth of cancer cells and eventually kills them.
More Info by Anukar Pharmacy
( Halaven 0.5 mg Injection, Eisai )
Suggestions
- Halaven 0.5 mg Injection helps treat breast cancer that has spread to other areas of the body.
- It is given by an injection into a vein (intravenously).
- It may cause dizziness and tiredness. Do not drive or do anything requiring concentration until you know how it affects you.
- Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for three months after you stop taking it.
- Your doctor may get regular blood tests done to monitor your blood cells and electrolyte levels during treatment with this medicine.
- Inform your doctor immediately if you notice any signs of infection such as fever, sore throat, rash or severe diarrhea while taking this medicine.
- It may cause numbness, tingling or pricking sensations in your hands and feet. Inform your doctor if this bothers you.
Warning by Anukar Pharmacy
( Halaven 0.5 mg Injection, Eisai )
Special precautions for Halaven 0.5 mg Injection, Eisai Heads up
| aspect | highlight | details |
|---|---|---|
|
Alcohol
|
There is no data available. Please consult doctor before consuming the drug. | |
|
Pregnancy
|
WEIGH RISKS VS BENEFITS | Halaven 0.5 mg Injection is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor. |
|
Lactation
|
Halaven 0.5 mg Injection is unsafe to use during lactation. Data suggests that the drug may cause toxicity to the baby, or the mother is suffering from a condition in which breastfeeding is not advisable. | |
|
Driving
|
There is no data available. Please consult doctor before consuming the drug. | |
|
Kidney
|
There is no data available. Please consult doctor before consuming the drug. | |
|
Liver
|
There is no data available. Please consult doctor before consuming the drug |
Suggestion by Anukar Pharmacy on missing a dose
( Halaven 0.5 mg Injection, Eisai )
If you miss a dose, kindly inform your doctor.
Disclaimer
The information of Anukar Pharmacy is for reference purpose only, and Anukar Pharmacy or Anukar Pharmacy or Anukar Pharmacy is not intended to be a replacement of professional medical advice, diagnosis, or treatment. Anukar Pharmacy suggest to ask the advice of a physician or any qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of anything you have learned from Anukar Pharmacy.